Miguel Coego Rios
Director of Finance/CFO at CENTOGENE N.V.
Net worth: 66 878 $ as of 29/04/2024
Network origin in Miguel Coego Rios first degree
Entity | Entity type | Industry | |
---|---|---|---|
80
| Subsidiary | Pharmaceuticals: Major | 80 |
Public Company | Miscellaneous Commercial Services | 26 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Miguel Coego Rios via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Centogene AG
Centogene AG Medical/Nursing ServicesHealth Services Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany. | Medical/Nursing Services | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact Public Communications Contact Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
BAXALTA INC | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Comptroller/Controller/Auditor | |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | General Counsel Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Undergraduate Degree | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Human Resources Officer Comptroller/Controller/Auditor | |
University of Michigan | College/University | Masters Business Admin Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel Sales & Marketing | |
RECKITT BENCKISER GROUP PLC | Household/Personal Care | Director/Board Member Director/Board Member Corporate Secretary General Counsel | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | President Public Communications Contact Corporate Officer/Principal | |
AVROBIO, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Director/Board Member | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
VBI VACCINES INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
EVOTEC SE | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
ArmaGen, Inc.
ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | Hospital/Nursing Management | Director/Board Member Director/Board Member Director/Board Member | |
BAXTER INTERNATIONAL INC. | Medical Specialties | Director/Board Member Director/Board Member Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Sales & Marketing Human Resources Officer | |
Iowa State University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member | |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
University of St. Gallen | College/University | Graduate Degree Graduate Degree | |
New York University | College/University | Masters Business Admin Graduate Degree | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
QIAGEN N.V. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree | |
LINEAGE CELL THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
MALLINCKRODT PLC | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Sidney Kimmel Medical College | College/University | Doctorate Degree Graduate Degree | |
REVANCE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
George Washington University | College/University | Undergraduate Degree Doctorate Degree | |
CORIUM INTERNATIONAL INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
QIAGEN MARSEILLE | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer |
Statistics
International
United States | 32 |
Germany | 6 |
United Kingdom | 5 |
France | 5 |
Switzerland | 3 |
Sectoral
Health Technology | 30 |
Consumer Services | 14 |
Health Services | 4 |
Commercial Services | 4 |
Consumer Non-Durables | 2 |
Operational
Director/Board Member | 504 |
Corporate Officer/Principal | 221 |
Independent Dir/Board Member | 150 |
Chairman | 145 |
Chief Executive Officer | 86 |
Most connected contacts
Insiders | |
---|---|
Peer Schatz | 83 |
Steven Gillis | 58 |
Ian Clark | 35 |
Kevin Rakin | 35 |
Flemming Ørnskov | 34 |
Hubert Birner | 27 |
William Burns | 27 |
Olivier Jean Bohuon | 24 |
Susan Kilsby | 24 |
Berndt A. E. Modig | 23 |
Patrick J. Langlois | 23 |
David Stout | 19 |
Thomas Johannes W. Dittrich | 18 |
S. Mathew | 18 |
Suzanne Bruhn | 18 |
- Stock Market
- Insiders
- Miguel Coego Rios
- Company connections